|
26
|
138
|
1o1wA |
Solution structure of the rnase h domain of the hiv-1 reverse transcriptase in the presence of magnesium |
|
15
|
99
|
1npaA |
Crystal structure of hiv-1 protease-hup |
|
0
|
17
|
1ncpN |
Structural characterization of a 39 residue synthetic peptide containing the two zinc binding domains from the hiv-1 p7 nucleocapsid protein by cd and nmr spectroscopy |
|
15
|
99
|
1npvA |
Crystal structure of hiv-1 protease complexed with ldc271 |
|
3
|
29
|
1nc8A |
High-resolution solution nmr structure of the minimal active domain of the human immunodeficiency virus type-2 nucleocapsid protein, 15 structures |
|
0
|
18
|
1ncpC |
Structural characterization of a 39 residue synthetic peptide containing the two zinc binding domains from the hiv-1 p7 nucleocapsid protein by cd and nmr spectroscopy |
|
13
|
99
|
1mrxA |
Structure of hiv protease (mutant q7k l33i l63i v82f i84v ) complexed with kni-577 |
|
17
|
99
|
1mtbA |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
16
|
99
|
1mtrA |
Hiv-1 protease complexed with a cyclic phe-ile-val peptidomimetic inhibitor |
|
17
|
99
|
1mt8A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
18
|
99
|
1mt7A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
18
|
99
|
1mt9A |
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy |
|
150
|
553
|
1mu2A |
Crystal structure of hiv-2 reverse transcriptase |
|
14
|
99
|
1mrwA |
Structure of hiv protease (mutant q7k l33i l63i) complexed with kni-577 |
|
15
|
99
|
1msnA |
The hiv protease (mutant q7k l33i l63i v82f i84v) complexed with kni-764 (an inhibitor) |
|
117
|
426
|
1mu2B |
Crystal structure of hiv-2 reverse transcriptase |
|
13
|
99
|
1n49A |
Viability of a drug-resistant hiv-1 protease variant: structural insights for better anti-viral therapy |
|
15
|
99
|
1msmA |
The hiv protease (mutant q7k l33i l63i) complexed with kni-764 (an inhibitor) |
|
47
|
203
|
1lv1A |
Crystal structure analysis of the non-active site mutant of tethered hiv-1 protease to 2.1a resolution |
|
146
|
534
|
1lwcA |
Crystal structure of m184v mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
134
|
554
|
1lweA |
Crystal structure of m41l/t215y mutant hiv-1 reverse transcriptase (rtmn) in complex with nevirapine |
|
114
|
422
|
1lw2B |
Crystal structure of t215y mutant hiv-1 reverse transcriptase in complex with 1051u91 |
|
117
|
423
|
1lwcB |
Crystal structure of m184v mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
16
|
99
|
1meuA |
Hiv-1 mutant (v82f, i84v) protease complexed with dmp323 |
|
146
|
534
|
1lw0A |
Crystal structure of t215y mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
16
|
99
|
1lzqA |
Crystal structure of the complex of mutant hiv-1 protease (a71v, v82t, i84v) with an ethylenamine peptidomimetic inhibitor boc-phe-psi[ch2ch2nh]-phe-glu-phe-nh2 |
|
49
|
146
|
1m9dC |
X-ray crystal structure of cyclophilin a/hiv-1 ca n-terminal domain (1-146) o-type chimera complex. |
|
144
|
554
|
1lwfA |
Crystal structure of a mutant hiv-1 reverse transcriptase (rtmq+m184v: m41l/d67n/k70r/m184v/t215y) in complex with nevirapine |
|
109
|
423
|
1lwfB |
Crystal structure of a mutant hiv-1 reverse transcriptase (rtmq+m184v: m41l/d67n/k70r/m184v/t215y) in complex with nevirapine |
|
3
|
55
|
1mfsA |
Dynamical behavior of the hiv-1 nucleocapsid protein; nmr, 30 structures |
|
17
|
99
|
1mesA |
Hiv-1 mutant (i84v) protease complexed with dmp323 |
|
16
|
99
|
1m0bA |
Hiv-1 protease in complex with an ethyleneamine inhibitor |
|
102
|
423
|
1lweB |
Crystal structure of m41l/t215y mutant hiv-1 reverse transcriptase (rtmn) in complex with nevirapine |
|
15
|
99
|
1merA |
Hiv-1 mutant (i84v) protease complexed with dmp450 |
|
141
|
539
|
1lw2A |
Crystal structure of t215y mutant hiv-1 reverse transcriptase in complex with 1051u91 |
|
116
|
422
|
1lw0B |
Crystal structure of t215y mutant hiv-1 reverse transcriptase in complex with nevirapine |
|
16
|
99
|
1metA |
Hiv-1 mutant (v82f) protease complexed with dmp323 |
|
17
|
99
|
1kzkA |
Je-2147-hiv protease complex |
|
0
|
9
|
1kjhP |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
14
|
99
|
1kj4A |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
18
|
99
|
1kjhA |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
1
|
8
|
1kj4P |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
18
|
99
|
1kjfA |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
0
|
9
|
1kjgP |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
18
|
99
|
1kj7A |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
16
|
99
|
1kjgA |
Substrate shape determines specificity of recognition recognition for hiv-1 protease: analysis of crystal structures of six substrate complexes |
|
19
|
99
|
1k2bA |
Combining mutations in hiv-1 protease to understand mechanisms of resistance |
|
17
|
99
|
1k2cA |
Combining mutations in hiv-1 protease to understand mechanisms of resistance |
|
17
|
99
|
1k6cA |
Lack of synergy for inhibitors targeting a multi-drug resistant hiv-1 protease |
|
133
|
539
|
1jlfA |
Crystal structure of y188c mutant hiv-1 reverse transcriptase in complex with nevirapine |
